Compare ORIC & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIC | CGBD |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | 2500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 837.3M | 826.2M |
| IPO Year | 2020 | N/A |
| Metric | ORIC | CGBD |
|---|---|---|
| Price | $8.82 | $11.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 8 |
| Target Price | ★ $19.73 | $12.92 |
| AVG Volume (30 Days) | ★ 1.4M | 720.8K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 14.42% |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.74 |
| Revenue Next Year | N/A | $1.80 |
| P/E Ratio | ★ N/A | $10.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.65 | $10.64 |
| 52 Week High | $14.93 | $14.48 |
| Indicator | ORIC | CGBD |
|---|---|---|
| Relative Strength Index (RSI) | 36.43 | 49.38 |
| Support Level | $7.90 | $11.19 |
| Resistance Level | $11.22 | $13.06 |
| Average True Range (ATR) | 0.55 | 0.29 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 6.47 | 36.45 |
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.